AME:NYSEAMETEK, Inc. Analysis
Data as of 2026-09-01 - not real-time
$231.17
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
AMETEK, Inc. is priced at $231.17 and its moving averages line up in bullish order, the shorter sitting above the longer. Across the trailing 30 sessions it lost 2.8%. RSI sits at 34.7, which reads as approaching oversold, and MACD momentum is bearish. Watch $229.60 as support and $261.16 as the nearer resistance level.
Multiples put this in fair territory: 33.8 times earnings against the sector's 28.6. The average analyst target implies 20.0% above today's level. Revenue is growing at 15.0% on a 20.0% profit margin. The 0.58% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 24.4%, a beta of 0.95 and a maximum drawdown of 13.7%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.
Multiples put this in fair territory: 33.8 times earnings against the sector's 28.6. The average analyst target implies 20.0% above today's level. Revenue is growing at 15.0% on a 20.0% profit margin. The 0.58% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 24.4%, a beta of 0.95 and a maximum drawdown of 13.7%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.
Top Market Events
Updated Jul 16, 2026 0 \- Earnings to be released before market opens on Tuesday, August 4, 2026 - BERWYN, Pa.Electronic products manufacturer AMETEK NYSE:AME in Q2 CY2026, with sales up 15% year on year to $2.AMETEK, Inc. NYSE: AME will issue its second quarter 2026 earnings release before the market opens on Tuesday, August...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 225.35
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 33.8 versus sector average of 28.6
- Trading above the 200-day average of 225.35
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 33.8 versus sector average of 28.6
- Analyst targets imply +20.0% versus the current price
- Profit margin of 20.0% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth15.00%
Profit Margin20.04%
P/E Ratio33.8
ROE14.56%
ROA8.16%
Debt/Equity20.52
P/B Ratio4.7
Op. Cash Flow$2.0B
Free Cash Flow$1.5B
Industry P/E28.6
Technical Analysis
TrendBullish
RSI34.7
Support$229.60
Resistance$261.16
MA 20$247.00
MA 50$241.46
MA 200$225.35
MACDBearish
VolumeStable
Fear & Greed Index93
Valuation
Fair Value$146.29
Target Price$277.50
Upside/Downside20.04%
GradeFair
TypeGrowth
Dividend Yield0.58%
Risk Assessment
Beta0.95
Volatility24.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.